NL-OMON29025尚未招募不适用
Docetaxel Impact on Metastastic Prostate cancer patients: a quality of Life Evaluation
none0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
研究概览
简要总结
A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age = 18 year
- •-Prostaatonline-participant (Patients that gave approval (in prostaatonline) for the use of data for scientific purposes)
- •-Treatment with docetaxel during the time of participation in prostaatonline
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate CancerProstate NeoplasmsNeoplasms, ProstaticProstate CancerNCT02649855National Cancer Institute (NCI)74
已完成
1 期
Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerProstate CancerNCT00574769University of Southern California27
已完成
2 期
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate CancerProstate CancerNCT01250717Beth Israel Deaconess Medical Center28
已完成
不适用
Personalizing Docetaxel Dosing in Advanced Prostate CancerProstate CancerNCT04823910Physiomics32
已完成
2 期
preoperative docetaxel chemotherapy and radical prostatectomy for metastatic prostate cancerMetastatic, untreated, high-riskProstate CancerJPRN-jRCT1031180387Horie Shigeo2